| Literature DB >> 17321930 |
Reed Y Nelson1, Brad Bretz, Talmage D Egan.
Abstract
A young, healthy adult man exhibited naloxone-reversible, prolonged apnea after a 4-hour infusion of remifentanil, which was used as the opioid component of a general endotracheal anesthetic. Clinical experience and pharmacokinetic simulations indicate that the apnea was clearly atypical.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17321930 DOI： 10.1016/j.jclinane.2006.05.024
Source DB: PubMed Journal: J Clin Anesth ISSN： 0952-8180 Impact factor: 9.452